rs145081708

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000484.4(APP):​c.592T>C​(p.Ser198Pro) variant causes a missense change. The variant allele was found at a frequency of 0.000319 in 1,614,066 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00040 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 1 hom. )

Consequence

APP
NM_000484.4 missense

Scores

3
9
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 5.45

Publications

13 publications found
Variant links:
Genes affected
APP (HGNC:620): (amyloid beta precursor protein) This gene encodes a cell surface receptor and transmembrane precursor protein that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. In addition, two of the peptides are antimicrobial peptides, having been shown to have bacteriocidal and antifungal activities. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Aug 2014]
APP Gene-Disease associations (from GenCC):
  • Alzheimer disease type 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • cerebral amyloid angiopathy, APP-related
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • ABeta amyloidosis, Arctic type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABeta amyloidosis, dutch type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABeta amyloidosis, Iowa type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABeta amyloidosis, Italian type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABetaA21G amyloidosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABetaL34V amyloidosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset autosomal dominant Alzheimer disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014454454).
BP6
Variant 21-26051070-A-G is Benign according to our data. Variant chr21-26051070-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 339645.
BS2
High AC in GnomAd4 at 61 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APPNM_000484.4 linkc.592T>C p.Ser198Pro missense_variant Exon 5 of 18 ENST00000346798.8 NP_000475.1 P05067-1A0A140VJC8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APPENST00000346798.8 linkc.592T>C p.Ser198Pro missense_variant Exon 5 of 18 1 NM_000484.4 ENSP00000284981.4 P05067-1

Frequencies

GnomAD3 genomes
AF:
0.000401
AC:
61
AN:
152184
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.0133
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.000481
GnomAD2 exomes
AF:
0.000684
AC:
172
AN:
251438
AF XY:
0.000640
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000463
Gnomad ASJ exome
AF:
0.0139
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000967
Gnomad OTH exome
AF:
0.000815
GnomAD4 exome
AF:
0.000311
AC:
454
AN:
1461882
Hom.:
1
Cov.:
31
AF XY:
0.000311
AC XY:
226
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33478
American (AMR)
AF:
0.000470
AC:
21
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0115
AC:
301
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000629
AC:
70
AN:
1112006
Other (OTH)
AF:
0.000993
AC:
60
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
32
64
96
128
160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000401
AC:
61
AN:
152184
Hom.:
0
Cov.:
32
AF XY:
0.000350
AC XY:
26
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41452
American (AMR)
AF:
0.000327
AC:
5
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0133
AC:
46
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68032
Other (OTH)
AF:
0.000481
AC:
1
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.535
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000636
Hom.:
1
Bravo
AF:
0.000382
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.000469
AC:
57
EpiCase
AF:
0.000491
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Alzheimer disease Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Jan 05, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Mar 24, 2016
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The S198P variant in the APP gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The S198P variant was not observed at any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The S198P variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret S198P as a variant of uncertain significance. -

not specified Benign:1
Mar 07, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Pathogenic
0.24
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.21
T;.;.;.;.;.;.;.
Eigen
Uncertain
0.39
Eigen_PC
Uncertain
0.32
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.83
T;D;D;T;D;T;D;T
M_CAP
Pathogenic
0.37
D
MetaRNN
Benign
0.014
T;T;T;T;T;T;T;T
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Uncertain
2.0
M;.;M;M;.;.;.;M
PhyloP100
5.5
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-1.7
N;N;N;N;.;N;N;N
REVEL
Uncertain
0.55
Sift
Uncertain
0.0070
D;D;D;D;.;D;D;D
Sift4G
Benign
0.088
T;T;T;D;T;D;D;T
Polyphen
0.96
D;D;D;D;.;.;D;.
Vest4
0.54
MVP
0.93
MPC
0.64
ClinPred
0.14
T
GERP RS
5.7
PromoterAI
0.0058
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.36
gMVP
0.31
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145081708; hg19: chr21-27423386; API